Maverick Capital

Superinvestor

Maverick Capital Ltd

SEC CIK: 0000934639
Manager: Lee Ainslie
Style: Hedge fund
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

ESPR holding history

Esperion Therapeutics, Inc. in every 13F filed by Maverick Capital, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ESPR overview All 13F holders of ESPR Full Q2 2026 holdings

Shares (Q4 2021): 0; Sold out in Q4 2021
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q2 2021

Holdings of ESPR by Maverick Capital, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2021	0	$0	0.0%	−49,973−100.0%	Sold out	Holders
Q3 2021	49,973	$602.0K	<0.1%	+4,981+11.1%	Added	Holders
Q2 2021	44,992	$952.0K	<0.1%	+44,992	New	Holders